Abstract
The aim of this study was to evaluate the role played in the behavioral expression of morphine withdrawal syndrome by protein kinases in the locus coeruleus and the periaqueductal gray matter. Two different families of specific protein kinases have been investigated: serine/threonine and tyrosine kinases.
Rats were implanted with cannulas into both the lateral ventricle and the locus coeruleus or the periaqueductal gray matter. Physical dependence was induced by chronic peripheral administration of morphine (from 7 to 30 mg/kg) and withdrawal syndrome was precipitated by injection of naloxone (2 μg) into the lateral ventricle. The administration of the serine/threonine kinase inhibitor 1-(5-isoquinolinylsulfonyl)2-methylpiperazine, H7 (1, 3, 10, and 30 nmol per side) into the locus coeruleus induced a strong attenuation of morphine withdrawal behavior. Signs related to the motor component of abstinence, such as jumping, rearing, and hyperactivity, were the most severely reduced. However, this effect was not dose-dependent, and the response was almost the same with all the doses used. A similar attenuation was observed after the injection of H7 (1, 3, and 10 nmol per side) into the periaqueductal gray matter, but in this case motor signs were less strongly reduced and a larger number of signs were modified, mainly when using the highest dose. The administration of the tyrosine kinase inhibitor 2-hydroxy-5-[N-[(2,5-dihydroxyphenyl)methyl] amino]-benzoic acid 3-phenylpropyl ester, KB23 (0.3, 1, and 3 nmol per side) into the locus coeruleus or the periaqueductal gray matter had no effect on the withdrawal syndrome behavior, except on teeth chattering.
These results suggest that, in the locus coeruleus and in the periaqueductal gray matter, serine/threonine kinases are implicated in the behavioral expression of morphine abstinence. In these brain structures, tyrosine kinases appear not to be involved.
Similar content being viewed by others
Abbreviations
- KB23:
-
2-hydroxy-5[N-[2,5-dihydroxyphenyl)methyl]amino]-benzoic acid 3-phenylpropyl ester
- H7:
-
1-(5-isoquinolinylsulfonyl)-2-methylpiperazine
References
Aghajanian GK (1978) Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine. Nature 276:186–188
Alkon DL, Nelson TJ (1990) Specificity of molecular changes in neurons involved in memory storage. FASEB J 4:1567–1576
Beitner-Johnson D, Berhow MT, Self DW, Wiegand SJ, Lindsay RM, Nestler EJ (1993) Neurotrophic factors influence chronic morphine action in the mesolimbic dopamine system. Neurosci Res Suppl 19:663
Bläsig J, Herz A, Reinhold K, Zieglgdnsberger S (1973) Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacology (Berl) 33:19–38
Bozarth MA, Wise RA (1984) Anatomically distinct opiate receptors fields mediate reward and physical dependence. Science 224:516–517
Chen H, Boiziau J, Parker F, Milliet P, Commerçon A, Tocque B, Le Pecq JB, Roques BP, Garbay C (1994) Structure-activity relationships in a series of 5-[(2, 5-dihydroxybenzyl)amino]salicylate inhibitors of EGF-receptor-associated tyrosine kinase:importance of additional hydrophobic aromatic interactions. J Med Chem 37:845–859
Chen Y, Yu L (1994) Differential regulation by cAMP-dependent protein kinase and protein kinase C of the mu opioid receptor coupling to a G protein-activated K + channel. J Biol Chem 269:7839–7842
Childers S (1991) Opioid receptor-coupled second messenger systems. Life Sci 48:1991–2003
Cox BM (1991) Molecular and cellular mechanisms in opioid tolerance. In: Basbaum A, Besson JM (eds) Towards a new pharmacotherapy of pain — Dahlem workshop reports. Wiley, New York, pp 137–149
Delay-Goyet P, Zajac JM, Roques BP (1989) Effects of repeated treatment with haloperidol on rat striatal neutral endopeptidase, and on μ- and ∂ opioid binding sites: comparison with chronic morphine and chronic kelatorphan. Neurosci Lett 103:197–202
Duman RS, Tallman JF, Nestler EJ (1988) Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in the locus coeruleus. J Pharmacol Exp Ther 246:1033–1039
Edelman AM, Blumenthal, DK, Krebs EG (1987) Protein serine/threonine kinases. Annu Rev Biochem 56:567–613
Esposito E, Kruszewska A, Ossowska G, Samanin R (1987) Noradrenergic and behavioural effects of naloxone injected in the locus coeruleus of morphine-dependent rats and their control by clonidine. Psychopharmacology (Berl) 93:393–396
Gucker S, Bidlack JM (1992) Protein kinase C activation increases the rate and magnitude of agonists-induced delta-opioid receptor down-regulation in NG108–15 cells. Mol Pharmacol 42:656–665
Guitart X, Nestler EJ (1989) Identification of morphine and cyclic AMP-regulated phosphoproteins (MARPPs) in the locus coeruleus and other regions of the rat brain: regulation by acute and chronic morphine. J Neurosci 9:4317–4387
Guitart X, Thompson MA, Mirante CK, Greenberg ME, Nestler EJ (1992) Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus. J Neurochem 58:1168–1171
Hanks SK, Quinn AM, Hunter T (1988) The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241:42–51
Harris GC, Aston-Jones G (1994) Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature 371:155–157
Hidaka H, Kobayashi R (1992) Pharmacology of protein kinase inhibitors. Annu Rev Pharmacol Toxicol 32:377–397
Hidaka H, Inagaki M, Kawamoto S, Sasaki Y (1984) Isoquinoline-sulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23:5036–5041
Kalivas PW, Steketee JD (1992) Possible transduction mechanisms mediating the acute and sensitized response to neurotensin in the ventral tegmental area. Ann NY Acad Sci 668:157–164
Koob GF, Wall TL, Bloom FE (1989) Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal. Psychopharmacology 98:530–534
Koob GF, Maldonado R, Stinus L (1992) Neural substrates of opiate withdrawal. Trends Neurosci 15:186–191
Maldonado R, Koob GF (1993) Destruction of the locus coeruleus decreases physical signs of opiate withdrawal. Brain Res 605:128–138
Maldonado R, Fournié-Zaluski MC, Roques BP (1992a). Attenuation of the morphine withdrawal syndrome by inhibition of catabolism of endogenous enkephalins in the periaqueductal gray matter. Naunyn-Schmiedeberg's Arch Pharmacol 345:466–472
Maldonado R, Stinus L, Gold LH, Koob GF (1992b) Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 261: 669–677
Malenka RC, Kauer JA, Perkel DJ, Mauk MD, Kelly PT, Nicoll RA, Waxham PA (1989) An essential role for postsynaptic calmodulin and protein kinase activity in long-term potentiation. Nature 340:554–557
Malinow R, Madison DV, Tsien RW (1988) Persistent protein kinase activity underlying long-term potentiation. Nature 335820–824
Malinow R, Schulman H, Tsien RW (1989) Inhibition of postsynaptic PKC or CaMKII blocks induction but not expression of LTP. Science 245:862–866
Marshall I, Weinstock M (1971) Quantitative method for assessing one symptom of the withdrawal syndrome in mice after chronic morphine administration. Nature 234:223–224
Matsuoka I, Maldonado R, Defer N, Noel F, Hanoune J, Roques BP (1994) Chronic morphine administration causes region-specific increase of brain type VIII adenylyl cyclase mRNA. Eur J Pharmacol 268:215–221
Nestler EJ, Tallman JF (1988) Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. J Pharmacol Exp Ther 33:127–132
Nestler EJ, Erdos JJ, Terwilliger R, Duman RS, Tallman JF (1989) Regulation of G-proteins by chronic morphine in the rat locus coeruleus. Brain Res 476:230–239
Nestler EJ, Hope BT, Widnell KL (1993) Drug addiction: a model for the molecular basis of neural plasticity. Neuron 11:995–1006
Nixon JS, Wilkinson SE, Davis PD, Sedgwick AD, Wadsworth J, Westmacott D (1991) Modulation of cellular processes by H7, a non-selective inhibitor of protein kinases. Agents Actions 32:188–193
Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, New-York
Rasmussen K, Beitner-Johnson DB, Krystal JH, Aghajanian GK, Nestler EJ (1990) Opiate withdrawal and the locus coeruleus: behavioral, electrophysiological, and biochemical correlates, J Neurosci 10:2308–2317
Rats PH (1990) Effect of the kinase inhibitor, H7, on stress, cross-bridge phosphorylation, muscle shortening and inositol phosphate production in rabbit arteries. J Pharmacol Exp Ther 252:253–259
Shahabi NA, Sharp BM (1993) Activation of protein kinase C rapidly down-regulates naloxone-resistant receptors for beta-endorphin on U937 cells. J Pharmacol Exp Ther 264:276–281
Shiekhattar R, Aston-Jones G (1993) Modulation of opiate responses in brain noradrenergic neurons by the cyclic AMP cascade: changes with chronic morphine. Neuroscience 57: 879–885
Steketee JD (1993) Injection of the protein kinase inhibitor H7 into the A10 dopamine region blocks the acute responses to cocaine: behavioral and in vivo microdialysis studies. Neuropharmacology 32:1289–1297
Stinus L, Le Moal M, Koob GF (1990) Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37:767–773
Taniguchi H, Sakano H, Hamasaki T, Kashiwa H, Ueda K (1989) Effect of protein kinase-C inhibitor (H-7) and calmodulin antagonist (W-7) on pertussis toxin-induced IL-1 production by human adherent monocytes. Comparison with lipopolysaccharide as a stimulator of IL-1 production. Immunology 67:210–215
Taylor JR, Elsworth JD, Garcia EJ, Grant SJ, Roth RH, Redmond Jr DE (1988) Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal. Psychopharmacology (Berl) 96:121–134
Terwilliger RZ, Beitner-Johnson D, Sevarino KA, Crain SM, Nestler EJ (1991) A general role for adaptations in G-protein and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 548:100–110
Terwilliger RZ, Ortiz J, Guitart X, Nestler EJ (1993) Chronic morphine administration increases levels of βARK in the rat locus coeruleus. Neurosci Res Suppl 19:50
Wei E, Loh HH, Way EL (1973) Brain sites of precipitated abstinence in morphine-dependent rats. J Pharmacol Exp Ther 185:108–115
Yao XR, Scott DW (1993) Inhibition of protein tyrosine kinase activity by herbimycin A prevents anti-mu but not LPS-mediated cell cycle progression and differentiation of splenic B lymphocytes. Cell Immunol 149:364–375
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maldonado, R., Valverde, O., Garbay, C. et al. Protein kinases in the locus coeruleus and periaqueductal gray matter are involved in the expression of opiate withdrawal. Naunyn-Schmiedeberg's Arch Pharmacol 352, 565–575 (1995). https://doi.org/10.1007/BF00169392
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00169392